This year, I get to start working on a research project that aims at using T cells to deliver immunosuppression to inflammation sites.

Immuno-oncology, researcher and clinician.

If things play out right, I can set up several research modules with potential to impact a broad range of immunological, haematological and cancer patients.

But, with laboratory research  (encompassing cells, mice, patient samples, viral vectors and DNA engineering) there is plenty of preparation that needs to be done in order to comply with regulatory agencies. I'll be reporting on all these aspects and building this project openly here. Let's go!